New Strains. No Problem.

Confidently test for the aggressive strains of SARS-CoV-2 with Asuragen’s Armored RNA Quant® Controls

New research shows that some emerging, aggressive strains of SARS-CoV-2 have a mutation in the Spike protein (S region) of the genome which can complicate its detection. Tests with primers spanning this region may be affected by dropouts since S region primer sequences will differ from the new mutation. The Armored RNA Quant® SARS-CoV-2 Panel is an effective control supporting the development of tests targeting these new variants.

The new Armored RNA Quant SARS-CoV-2 SV2 (Spike Variant 2) control provides safe and reliable detection of Alpha (B.1.1.7), Beta (B.1.351), Gamma (B.1.1.28), Delta (B.1.617.2), and Omicron (B.1.1.529) variant strains of the novel Coronavirus.